Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
Jon Bridges
openalex +2 more sources
Long-term outcomes of biodegradable versus 2nd generation durable polymer drug-eluting stents in PCI: Protocol for a systematic review and meta-analysis. [PDF]
Thuemmler RJ +5 more
europepmc +1 more source
Serum uric acid to creatinine ratio and long-term target vessel events in diabetes patients undergoing PCI with drug-eluting stents implantation: a retrospective study. [PDF]
Cui P, Wang S, Zhang Z, Wang R.
europepmc +1 more source
Long-term clinical and angiographic outcome of T-and protrusion technique with ultrathin strut drug eluting stents. [PDF]
Dézsi CA +8 more
europepmc +1 more source
Polymer-Free Versus Biodegradable Polymer Drug-Eluting Stents in Coronary Artery Disease: Updated Systematic Review and Meta-Analysis of Clinical, Angiographic, and OCT Outcomes. [PDF]
Marchetta M +13 more
europepmc +1 more source
Drug-eluting stents versus bare-metal stents for intracranial atherosclerotic stenosis: a systematic review and meta-analysis. [PDF]
Gong H +8 more
europepmc +1 more source
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study. [PDF]
von Koch S +8 more
europepmc +1 more source
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial. [PDF]
Renkens MPL +15 more
europepmc +1 more source
Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris. [PDF]
Meng H +5 more
europepmc +1 more source

